Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double ‐blind crossover trial

ConclusionsNadolol significantly worsened insulin sensitivity, glycemia, and disposition index in patients with liver cirrhosis. These findings may have significant clinical implications because cirrhosis is already associated with an increased prevalence of diabetes.

Source: Diabetes/Metabolism Research and Reviews - November 9, 2016 Category: Endocrinology Authors: Wai Gin Lee, Rinki Murphy, John L. McCall, Edward J. Gane, Mattias Soop, Andrea Tura, Lindsay D. Plank Tags: RESEARCH ARTICLE Source Type: research